SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : VaxGen Inc.-The 1st AIDS Vaccine in Phase 3 HumanTrials

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: Victor Lazlo who wrote (238)2/28/2003 9:18:26 AM
From: noel berge   of 250
 
What's to argue with?

Market ever heading south, attenuating and in a ever negative slope or glide path to probably 5000-6000. Sector itself, for new discoveries is truly a fine area if one finds a new product of great value.

I DO suggest that VXGN has several viable revenue streams that will make one wealthy, especially when you can get this stock for a few dollars today, after the irrational reaction to the negative press on AIDVAX.

However, after the scheduled Baniff conference on AIDS and VXGN presents the full data for discussion, you will see FDA approval and new funding coming for this one!!

I will be buying more at this level and preparing for good times.

Truly a personal call, but there are those of us who buy a business and there are those that buy stocks. There are those that look into a company and there are those that read tea leaves, charts and static numbers. I am in the former category in each case.

But, then again, I have owned my own company before, gotten involved and worked my ass off for something, betting on it with my full being. Like the best investment counsels I have studied, finding and buying company is what works.

I think this is one of them.

Of course, my opinion and nothing more,
Noël
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext